Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
about
Vilazodone for the Treatment of Depression: An UpdateVilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapySelective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisSexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trialsA Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.Evaluation of the efficacy and safety of vilazodone for treating major depressive disorderEfficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials.A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorderThe Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone.Vilazodone: a review in major depressive disorder in adults.Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective.Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials.The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone.Assessment and management of sexual dysfunction in the context of depression.Efficacy of antidepressants: bias in randomized clinical trials and related issues.A 12-week Comparative Prospective Open-label Randomized Controlled Study in Depression Patients Treated with Vilazodone and Escitalopram in a Tertiary Care Hospital in North India.Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials.A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
P2860
Q26745605-83E0E954-9ED1-492D-9EE8-72BDC57FBB30Q28083651-AAA91D76-7965-4310-B68F-F3EA941DB8A7Q28736049-CC6DDD27-BDCC-4BC2-A4AF-6E0E4E05DBB8Q30384691-0F970F9E-CB33-49ED-879F-CAC7EBBCF395Q30491758-B7F47768-E45F-42A0-8D4E-6BF689B81937Q34502250-69E24ADE-8BBC-4C5F-B67A-4F77B6E33E1BQ34672417-82EB5CCE-2257-4070-8769-11DE2ADF0031Q35934859-8DF550AE-1925-46E6-A269-EDEF1C93715FQ36216847-72C3A165-1DD5-4F7A-A126-A3EA8E59936DQ36366194-92E6512B-5EE3-4F9A-969C-4F9BB47BD95BQ36825752-1D8D8172-107F-4A05-B7D6-20CC36E1780DQ37115879-60434202-1E17-41D4-AF2B-1B1466B5D354Q38615116-4D7551D8-44FE-4FEA-97A8-A13CCD2B596AQ39441213-62F8878A-F225-49A4-8C93-51F93D21D3ADQ42061953-60F87805-26E5-40BF-ABCE-D57EF6ADF839Q47141387-0202669A-D925-4F8F-959B-87C3C0B6FA1DQ47653061-CB4990D0-C410-4641-AC3C-2961688F911AQ47772123-1E41DF6C-0E51-4D4B-9F6E-401D2EBE8AFDQ49593933-21267916-F148-468F-87B5-D257DC8FB8F7Q52613387-53EB1C4F-82C6-4AB9-8316-AB9A82378870Q53414630-94502316-FB3D-421A-B51C-529D234603DCQ55054440-08B2F8D9-C018-4B6E-87F3-2A16371FE307Q59128329-8EF85576-0966-434E-9BDF-DA1B80AD24DE
P2860
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@ast
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@en
type
label
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@ast
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@en
prefLabel
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@ast
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@en
P2093
P2860
P1476
Efficacy and safety of vilazod ...... ind, placebo-controlled trial.
@en
P2093
Carl Gommoll
Dalei Chen
Maju Mathews
Rene Nunez
P2860
P356
10.1097/YIC.0000000000000057
P577
2015-03-01T00:00:00Z